Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preoperative bevacizumab in combination with paclitaxel and carboplatin in surgically resectable non-small cell lung cancer.

× No keyword cloud information.

5 in total

1. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.

Authors: Katherine M W Pisters; Eric Vallières; John J Crowley; Wilbur A Franklin; Paul A Bunn; Robert J Ginsberg; Joe B Putnam; Kari Chansky; David Gandara
Journal: J Clin Oncol Date: 2010-03-15 Impact factor: 44.544

2. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

Authors: Alan Sandler; Robert Gray; Michael C Perry; Julie Brahmer; Joan H Schiller; Afshin Dowlati; Rogerio Lilenbaum; David H Johnson
Journal: N Engl J Med Date: 2006-12-14 Impact factor: 91.245

3. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

Authors: J A Roth; F Fossella; R Komaki; M B Ryan; J B Putnam; J S Lee; H Dhingra; L De Caro; M Chasen; M McGavran
Journal: J Natl Cancer Inst Date: 1994-05-04 Impact factor: 13.506

4. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

Authors: R Rosell; J Gómez-Codina; C Camps; J Maestre; J Padille; A Cantó; J L Mate; S Li; J Roig; A Olazábal
Journal: N Engl J Med Date: 1994-01-20 Impact factor: 91.245

5. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

Authors: David H Johnson; Louis Fehrenbacher; William F Novotny; Roy S Herbst; John J Nemunaitis; David M Jablons; Corey J Langer; Russell F DeVore; Jacques Gaudreault; Lisa A Damico; Eric Holmgren; Fairooz Kabbinavar
Journal: J Clin Oncol Date: 2004-06-01 Impact factor: 44.544

5 in total

3 in total

Preoperative bevacizumab in combination with paclitaxel and carboplatin in surgically resectable non-small cell lung cancer.

1. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.

2. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

3. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

4. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

5. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

1. Is performing lobectomy after the use of bevacizumab for a lung tumor dangerous?

Review 2. [Application of Bevacizumab in Non-small Cell Lung Cancer].

3. Bevacizumab as first-line therapy in advanced non-small-cell lung cancer: a brazilian center experience.